News Daily News FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis Michael O'Riordan May 01, 2025
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection L.A. McKeown August 23, 2022
News Daily News FDA Approves Portico TAVI Valve, Paving the Way for Third US Device Shelley Wood September 20, 2021
News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Conference News STS 2020 TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge Yael L. Maxwell January 29, 2020
News Daily News Sapien 3 Valve Approved in Europe for Low-Risk Patients Michael O'Riordan November 06, 2019
News Daily News FDA Approves Lotus Edge, Ushering Third Device Into US Market Shelley Wood April 24, 2019
News Industry News Boston Scientific Receives FDA Approval for LOTUS Edge™ Aortic Valve System April 23, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2019 Caitlin E. Cox January 31, 2019
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018
News Daily News ‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions Yael L. Maxwell August 17, 2018
News Daily News LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR Yael L. Maxwell March 01, 2018
News Daily News FDA Expands CoreValve Indication to Include Intermediate-Risk Patients Michael O'Riordan July 10, 2017
News Daily News FDA Clears Sentinel Cerebral Protection Device for Use During TAVR Shelley Wood June 05, 2017
News Daily News FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy L.A. McKeown October 27, 2016